Generics BulletinLupin and Zentiva have announced a license and supply agreement for the commercialization of Lupin’s Cimzia (certolizumab pegol) biosimilar “across multiple markets globally.” “Zentiva will oversee co
Generics BulletinLupin has struck a deal aimed at expanding its footprint in China, allying with local player Sino Universal Pharmaceuticals for a partnership to commercialize the Indian firm’s tiotropium dry powder i
Pink SheetLupin must wait until at least January 2030 to launch its proposed generic of Harmony Biosciences ’ Wakix (pitolisant hydrochloride) after agreeing to settle patent infringement litigation. The agre
Generics BulletinAs the UK generics market sees increasing competition on simple commodity generics, with more generics rivals on the horizon from geographies such as China, Lupin is increasingly moving into areas whe